started · updated
Amyris to acquire Oobli to expand sweet protein technology
Amyris, a biomanufacturing company, has announced an agreement to acquire Oobli, a developer of fermentation-produced sweet proteins. The acquisition aims to combine Amyris’ industrial fermentation and strain engineering capabilities with Oobli’s proprietary technology designed to reduce sugar in food and beverage products.
Oobli has spent approximately a decade developing processes to produce sweet proteins through fermentation. These proteins, such as brazzein, monellin, and thaumatin, occur naturally in rare equatorial fruits and berries but are difficult to harvest at scale. By inserting DNA sequences into yeast strains, Oobli can produce these proteins in fermentation tanks. These proteins can be hundreds to thousands of times sweeter than conventional sugar and interact directly with sweet taste receptors.
The transaction follows Amyris’ recent expansion of manufacturing capacity at its fermentation facility in Barra Bonita, Brazil. The companies stated that existing customer commitments and brand partnerships will continue without interruption as they prepare for the combination. The purchase price was not disclosed, and the deal is expected to close in the coming weeks.
Entities
Ali Wing · Amyris · Barra Bonita · Oobli